Scarica l'app Stockscreener
67.51
3.96%
2.57
Bridgebio Pharma Inc Azioni (BBIO) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
25.27%
243.68
|
194.51 | 154.18 | 120.70 | 110.56 |
| Cost Of Revenue |
51.38%
15.05
|
9.939 | 8.107 | 6.563 | 3.653 |
Selling, General, and Administrative
|
13.65%
186.26
|
163.90 | 158.09 | 137.62 | - |
| Costs And Expenses |
16.74%
350.75
|
300.47 | 293.74 | 265.90 | 244.84 |
| Operating Income/Loss |
1.06%
-107.08
|
-105.96 | -139.56 | -145.20 | -134.28 |
| Nonoperating Income/Loss |
19.45%
-48.81
|
-60.60 | -55.19 | -41.28 | -47.38 |
| Income/Loss From Equity Method Investments |
64.80%
-6.435
|
-18.28 | -21.03 | -15.83 | -20.19 |
| Income/Loss From Continuing Operations Before Tax |
-155.89
|
- | -194.75 | -186.48 | -181.66 |
| Income Tax Expense/Benefit |
-
|
- | -0.12 | -1.545 | 2.10 |
| Net Income/Loss |
6.40%
-155.89
|
-166.56 | -194.63 | -184.94 | -183.76 |
| Attributable To Noncontrolling Interest |
46.30%
-3.675
|
-2.512 | -1.772 | -2.194 | -1.855 |
| Basic Average Shares |
0.51%
195.79
|
194.79 | - | 191.85 | 190.52 |
| Diluted Average Shares |
0.51%
195.79
|
194.79 | - | 191.85 | 190.52 |
| Basic Earnings Per Share |
7.14%
-0.78
|
-0.84 | - | -0.95 | -0.95 |
| Diluted Earnings Per Share |
7.14%
-0.78
|
-0.84 | - | -0.95 | -0.95 |
3.80%
1.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):